Yotam Alroy

Huge news for team Brevel! 🥳 We've been granted another significant investment from the Israel Innovation Authority – almost $500k. This grant will be dedicated to taking our upstream process to the next level. With a stable process in place, now we’ll use this support to push boundaries and further optimize every aspect, including: ✨ Improving quality ✨ Increasing protein content & concentration ✨ Enhancing growth rates ✨ Boosting energy efficiency ✨ Optimizing media composition ✨ Further reducing production costs By fine-tuning our illuminated fermentation technology, we’re making microalgae protein production even more scalable, sustainable, and accessible — moving closer to a food system that works better for everyone. 🌱💡 A huge thank you to the Israeli Innovation Authority for backing our vision, and to our incredible team, partners, and investors who make progress like this possible. 💚 #Microalgae #Alternativeprotein #Plantbased #Foodtech #Investment

190

‏28‏ ‏תגובות‏

🚀 Welcoming Insignito Solutions Ltd to the ICI Fund Portfolio! Excited to share our investment in Insignito, an Israeli startup pioneering the field of #drone #acoustics. Insignito's AI-powered technologies dramatically reduce drone noise, enable accurate long-range acoustic detection, and provide mission planning tools that optimize performance in real-world environments. What makes Insignito truly stand out is its founding team — Itay Nourian (CEO), Yarden Eilat (CTO), and Dor Ruf (VP R&D) — three longtime colleagues from the Israeli Air Force who bring deep technical expertise, operational excellence, and the trust that comes from years of working together in high-stakes environments. We believe Insignito has the potential to set the global standard for drone acoustics, opening new opportunities across commercial, defense, and urban applications. 👏 Grateful to back this visionary team and excited to see what’s ahead. 📩 Read more about Insignito in our latest newsletter: https://lnkd.in/dgM5u24d . Innovation • Community • Intelligence #DroneTechnology #AIInnovation #DeepTech #IsraeliStartups #VentureCapital #FutureOfFlight #AerospaceInnovation Timothy Jones Prof. Yaron Wolfsthal Aviv Nizri Ari Goldfarb

67

‏8‏ ‏תגובות‏

Thank you to Sigalit Ben Hayoun and Yael Steinhart for inviting me to talk to Tel Aviv University Alumni Organization — and to Assaf Gilad for moderating the discussion. Time really does fly 😅 and it was a real privilege to be back to discuss just how much has changed in tech since I first started, including the recent groundbreaking new leaps into AI. What’s incredible is the pace of innovation in this field. Current market estimates range from 3-7 years until AGI (Artificial General Intelligence) is achieved (AI systems surpassing human cognitive abilities). When this is achieved one can expect the pace of change to be the fastest we’ve ever seen in history 📈 Technology and AI is neutral - neither good or bad. What matters is what we (humans) choose to do with it. With good intent, AGI could help solve some of the biggest global challenges (health, longevity, climate change, scientific discovery). With bad intent, it can create even bigger global challenges with significant risks. That is why Google’s motto on AI is so important - to be “bold and responsible”. The stakes have never been higher. Hope humanity rises to the moment, does the right thing, and makes the right choices 🌍 Adding below in comments the link to the full discussion (tip: if you just want a summary, past the link directly into Gemini 🪄) #TelAvivUniversityAlumni #GoogleAI

52

‏3‏ ‏תגובות‏

Had the pleasure of joining אלטרנטיבה - פודקאסט הקיימות של ישראל, an inspiring Tel Aviv podcast and community that drives social and environmental change. We covered a lot of ground: → Moving from the software world into climate, and why constant reinvention matters. → The big gap between selling software vs. hardware (and how that changes GTM). → Why defining your ICP early can make or break your first customers. → The role of humility,  knowing your blind spots and closing them before you build. It was a thoughtful conversation, thank you Daniel Baron for having me. To give it a watch: https://lnkd.in/da4Yg4rF

54

‏2‏ ‏תגובות‏

#Deeptech Venture Capital funds? The new Yozma #FoF by the Israel Innovation Authority is open for applications until November 4th, to support Israeli or foreign Venture Capital funds who have a dedicated Israeli focused Deeptech fund, led by experienced GPs. * Winners will recieve an investment of between $4m to $10m per fund. *Min size of targeted fund: $32M, Max IIA investment: 12.5% of the fund size. * All fund sizes are eligible, from early-stage to growth-stage investors. The deadline for submission of applications is November 4th, 2025 For more details: https://lnkd.in/d6_r6EQy

51

‏1‏ ‏תגובה‏

IVC presented a special analysis at the AI Digital Health conference hosted by People & Computers. The study examined active companies in the field, their funding, and other relevant factors. According to the data, 55% of Israeli AI companies focus on enterprise software and infrastructure, while over 300 companies (13%) work in digital health. The Israeli digital health cluster includes 564 companies. Only 22 companies have more than 100 employees, indicating that the ecosystem is still relatively young. More than half of the companies are at the Seed or R&D stage. On the other hand, 44% are selling products to their markets. There are 338 Israeli AI companies focused on digital health, with 200 of them founded in the past five years. Israeli tech companies raised $93 billion in 6554 deals. Israeli AI companies raised $50 billion in this period. AI digital health companies raised $3.5 billion.

30

Tech continues to drive Israel’s economic resilience, but beneath the surface the ecosystem is showing signs of strain and health tech is feeling the pressure most. The announcement of clinical AI company Aidoc's recent $150 million raise, backed by General Catalyst, Square Peg, nVentures (NVIDIA’s venture capital arm), and four major U.S. health systems, is a sign of what is still possible: when the science is solid, the platform is ready, and the value is global, capital will follow. This is proven by the over 45 million patients currently benefitting from Aidoc's integration across more than 150 health systems. Aidoc’s success is an outlier today, but it should be the model. As the largest sector in Israeli innovation, with over 1,600 companies, health tech should be a source of strength. Instead, in the first half of 2025, it drew just $630 million in private funding — the lowest total in five years. Median deal sizes are shrinking, and time from seed to Series A has stretched to 54 months, pointing to deep structural challenges rather than a short-term slowdown. Capital is flowing elsewhere, toward sectors with faster cycles and clearer paths to scale. Cybersecurity raised $2.2 billion with a median round size of $25 million in H1 2025, while business software led all sectors with $3.2 billion. Health tech is struggling to compete for attention, investment, and talent. These trends are part of a broader shift. Israel’s global innovation position is narrowing, infrastructure hasn’t kept pace with the needs of deep tech, and overreliance on a few sectors is leaving others under-supported. Talent shortages and limited access to global markets are compounding the pressure. At Startup Nation Central, we are seeing this firsthand. Through our work with the 8400 The Health Network Health Network and across the ecosystem, the signals are clear. Health tech is underfunded and underprioritized at a time when its relevance has never been greater. Still, the fundamentals are here. Israel has a strong scientific foundation, a deep pool of entrepreneurial talent, a world-class healthcare system, and health professionals with a track record of innovation. Add to that a growing global demand for health solutions, and the potential is clear. With targeted investment, a renewed focus on translational research, and the right strategic partnerships, health tech can not only recover but take the lead as Aidoc has. The opportunity is real and so is the urgency to act on it. 

108

‏9‏ ‏תגובות‏